Archives
Cochrane Special Collection | De-implementation of low-value health care: resource prioritization in the COVID-19 pandemic era.
23 Sep, 2021 | 10:13h | UTCEditorial: Making wise choices about low‐value health care in the COVID‐19 pandemic – Cochrane Library
Commentary: Choosing health care wisely when resources are scarce – Evidently Cochrane
Commentaries on Twitter
📰Our new editorial @cochranecollab: Making wise choices about low‐value health care in the COVID‐19 pandemic👉https://t.co/qABVg7emRi
Linked Special Collection on low-value care: https://t.co/fstV8P8OQS#FreeAccess pic.twitter.com/h9KZGUm2kp
— Juan Franco 🏳️🌈 (@juan_francomd) September 22, 2021
Sadly, some medical interventions are in use despite evidence against them. With @Cochrane_SH, we have published a Special Collection of Cochrane reviews of Low Value Care interventions and described the issue in an Editorial. We cannot afford wasted HC. https://t.co/PXUhaMZud2
— Karsten Juhl Jørgensen (@KarstenJuhl) September 22, 2021
Randomized phase 1/2 trial: Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in children and adolescents aged 3–17 years.
23 Sep, 2021 | 10:16h | UTC
‘Not a zero-sum game’: Sharing vaccines is in countries’ best interests.
23 Sep, 2021 | 10:09h | UTC‘Not a zero-sum game’: Sharing vaccines is in countries’ best interests – YaleNews
Original article: National interest may require distributing COVID-19 vaccines to other countries – Scientific Reports
Commentary on Twitter
"when US has reached the threshold for domestic herd immunity, it would be optimal to donate doses to other countries, as this would allow for a sharp reduction in the inflow of infected individuals from abroad"
– Modeling by @SaadOmer3, @amynmalik & co https://t.co/NFfp39tde6— Mushfiq Mobarak (@mushfiq_econ) September 16, 2021
Systematic review: Clinical characteristics of multisystem inflammatory syndrome in adults.
23 Sep, 2021 | 10:12h | UTC
Commentary on Twitter
Multisystem inflammatory syndrome has been reported in adults worldwide but may be hard to distinguish from acute biphasic #COVID19 and postacute sequelae of COVID-19. More research is needed to understand this emerging clinical entity. https://t.co/OnerzsZKVB
— JAMA Network Open (@JAMANetworkOpen) September 22, 2021
WHO releases new compendium of innovative health technologies for COVID-19 and other priority diseases.
23 Sep, 2021 | 10:03h | UTC
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.
23 Sep, 2021 | 10:08h | UTC
Commentary on Twitter
Flaws in ivermectin data suggest that COVID-19 meta-analyses need rethinking
Correspondence from Jack Lawrence @GidMK @K_Sheldrick and colleagues https://t.co/lUqXX9DQjO pic.twitter.com/Oh848X1VGv
— Nature Medicine (@NatureMedicine) September 22, 2021
AHA Scientific Statement: Sleep‐disordered breathing and cardiovascular disease in children and adolescents.
23 Sep, 2021 | 10:02h | UTCNews release: Obstructive sleep apnea is common in kids and may impact blood pressure, heart health – American Heart Association
ERS clinical practice guidelines on treatment of sarcoidosis.
23 Sep, 2021 | 10:00h | UTCERS clinical practice guidelines on treatment of sarcoidosis – European Respiratory Journal
New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution.
23 Sep, 2021 | 10:05h | UTCNews release: New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution – World Health Organization
Original Guideline: WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide
Executive Summary: WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide
Commentaries:
Millions of deaths could be avoided under new air quality guidelines, WHO says – CNN
WHO slashes guideline limits on air pollution from fossil fuels – The Guardian
Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system—part V, knee.
23 Sep, 2021 | 09:59h | UTCSee other articles in the series: Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system.
Consensus Document: Evaluation and management of cancer patients presenting with acute cardiovascular disease—Part 1: acute coronary syndromes and acute pericardial diseases.
23 Sep, 2021 | 10:01h | UTCRelated:
Brazilian Cardio-oncology Guideline – 2020
Commentary on Twitter
📌Evaluation & Management of Cancer 👥presenting w/ Acute Coronary Syndromes & Acute Pericardial diseases. Consensus📝from #ACVC & the @escardio council of #CardioOncology#CardioEd #CardioTwitter #CardioOnc #EchoFirst pic.twitter.com/QSNOv7uFK7
— Diego Segura-Rodríguez (@SeguraCardio) September 19, 2021
Expert Analysis | Colchicine in acute coronary syndrome: when to commence?
23 Sep, 2021 | 09:56h | UTCColchicine in Acute Coronary Syndrome: When to Commence? – American College of Cardiology
Related:
Review: Colchicine and the heart.
M-A: Colchicine administration for percutaneous coronary intervention
M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease
Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease
Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease
#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome
Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome
Importance of distinguishing between asthma and chronic obstructive pulmonary disease in primary care.
23 Sep, 2021 | 09:57h | UTC
Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition.
23 Sep, 2021 | 09:51h | UTC
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy.
23 Sep, 2021 | 09:52h | UTC
Commentaries on Twitter
Just published on the @JAHA_AHA: from the original 1994 ITF criteria to the Padua criteria for the diagnosis of arrhythmogenic cardiomyopathy. #arvd #arvc #cmr #cardiomyopathy #Cardiology@DCorradoCardio @Cipeciop1964 @albcipri6 https://t.co/zPA2g2hsNg
— Alessandro Zorzi (@AlessandroZor14) September 18, 2021
📌Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy#CardioEd #CardioTwitter #ePeeps @JAHA_AHA pic.twitter.com/WKPruB99kQ
— Diego Segura-Rodríguez (@SeguraCardio) September 18, 2021
Phenotypes and subphenotypes of delirium: a review of current categorizations and suggestions for progression.
23 Sep, 2021 | 09:54h | UTC
Perspective | Sorry, a Coronavirus Infection Might Not Be Enough to Protect You – “Anyone who’d rather have COVID-19 than get vaccinated is taking two gambles: that immunity will stick around, and that symptoms won’t”.
22 Sep, 2021 | 10:23h | UTCSorry, a Coronavirus Infection Might Not Be Enough to Protect You – The Atlantic
[Press release – not published yet] J&J says booster shot at two months provided 75% protection against moderate to severe COVID-19 globally and 94% of such cases in the U.S.
22 Sep, 2021 | 10:26h | UTCCommentaries:
Johnson & Johnson says additional dose boosts Covid vaccine efficacy – STAT
J&J booster 94% effective against severe COVID, company says – CIDRAP
Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds – CNN
Commentaries on Twitter
(thread – click for more)
📍BREAKING—At last—new data on 2-doses of Johnson & Johnson's #vaccine (doses 56 days apart) is 94% effective against symptomatic #COVID19, thus comparable to Moderna/Pfizer. And 100% effective against severe COVID. Booster for 1 dose works well too. 🧵https://t.co/3nPkodOjuG pic.twitter.com/DizjWt9NYX
— Eric Feigl-Ding (@DrEricDing) September 21, 2021
(thread – click for more)
https://twitter.com/hildabast/status/1440363761299124229
[Preprint] SARS-like viruses may jump from animals to people hundreds of thousands of times a year.
22 Sep, 2021 | 10:22h | UTCSARS-like viruses may jump from animals to people hundreds of thousands of times a year – Science
Original study: A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia – medRxiv
Related:
Did the coronavirus jump from animals to people twice? – Nature
The Origins of SARS-CoV-2: A Critical Review.
Fauci says natural origins theory of coronavirus is still the most likely.
Interpreting SARS-CoV-2 Test Results.
22 Sep, 2021 | 10:24h | UTCInterpreting SARS-CoV-2 Test Results – JAMA
Consensus Conference: Critically ill cancer patient’s resuscitation.
22 Sep, 2021 | 10:16h | UTC
Commentary on Twitter
Critical care for cancer pts: 🇧🇪/🇫🇷 consensus conference
1⃣Triage for #ICU admission
2⃣Ventilatory support & #ECLS
3⃣RRT
4⃣Hemodynamic support
5⃣Benefit of CPR?
6⃣Intensive monitoring
7⃣Specific considerations
8⃣Blood products
9⃣Training for ICU doctorshttps://t.co/bqPR1v0Um1 pic.twitter.com/GNvooA85IM— Intensive Care Medicine (@yourICM) September 21, 2021
Long Covid – The illness narratives.
22 Sep, 2021 | 10:19h | UTCLong Covid – The illness narratives – Social Science & Medicine
Commentary on Twitter
https://twitter.com/trishgreenhalgh/status/1439199576158883843
The fight to manufacture COVID vaccines in lower-income countries.
22 Sep, 2021 | 10:21h | UTCThe fight to manufacture COVID vaccines in lower-income countries – Nature
Essential Emergency and Critical Care: A consensus among global clinical experts.
22 Sep, 2021 | 10:07h | UTCEssential Emergency and Critical Care: a consensus among global clinical experts – BMJ Global Health
News releases:
40 steps to reduce deaths from critical illness – London School of Hygiene & Tropical Medicine
40 simple steps to reduce deaths from critical illness – Karolisnka Institutet
Commentary on Twitter
Blueprint for hospitals on how to reduce preventable deaths due to critical illness has been set out 🏥
New study in @GlobalHealthBMJ outlines 4⃣0⃣ steps to prioritise essential care & improve #pandemic preparedness.
👉 https://t.co/hpVMXUZ1vb #COVID19 #PublicHealth pic.twitter.com/5BBZDCVkFM
— London School of Hygiene & Tropical Medicine (@LSHTM) September 21, 2021
AHA Scientific Statement: Weight-loss strategies for prevention and treatment of hypertension.
22 Sep, 2021 | 10:09h | UTCNews release: Weight-loss meds, surgery could fight obesity-related high blood pressure – American Heart Association